Appendix 4C - quarterly
Filed with ASX · · 8 pages · English
Earlier from Anagenics
- Cellmid signs distribution agreement for Fillerina
- Appendix 4D and Half Year Accounts
- Record 2M sales for Cellmid FGF5 inhibitors
- Cellmid quarterly operational update
- Cellmid placement to strategic investor
Later from Anagenics
- Cellmid secures Bloomingdales USA partnership for evolis
- Cellmid to commence selling of evolis into Chinese market
- Cellmid updates on distribution of evolis
- Cellmid Share Placement Raises $9M
- Cellmid Share Purchase Plan
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics